Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Double E who wrote (1324)	7/18/1998 8:03:00 AM
From: majormember	Read Replies (2) \| Respond to of 4140

Thought this post on VISX Yahoo thread might be of interest... Though this is certainly not true DD, it is anecdotal and therefore of interest IMHO....Regards, Skane ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ I have a big block of both snrs and visx. I'm currently lightening up on visx and buying more snrs. There are simply more hyperopes than myopes out there, And snrs procedure is non-invasive--merely shrinking the collagen, rather than cutting. It's a good time to accumulate snrs, what with a lot of nervous nellies selling snrs because of delays in snrs approval for relisting on nasdaq, which has nothing to do with the phase three fda tests which are now complete and did fantastic. I'd like to see visx buy snrs while it's still below 10. It would be a marriage made in heaven--and, hell, both companies are practically within shouting distance of one another. Visx would be picking up some good people and good patents if it acted promptly. A year from now, snrs won't be cheap any more. Probably in the high teens or low 20s.